Catalyst Pharmaceuticals CPRX
CPRX
$31.49 +0.00 (+0.00%)
At close: Jul 21, 2026 · 4:00 PM EDT

Catalyst Pharmaceuticals (CPRX) Cash & Current Investments (2010 - 2026)

Updated

Catalyst Pharmaceuticals (CPRX) recorded Cash & Current Investments of $755.86 million in Q1 2026, up 30.2% from $580.66 million a year earlier and up 6.6% from the prior quarter.

Analysis

Catalyst Pharmaceuticals (CPRX) Cash & Current Investments (2010 - 2026) Analysis & Trends

At the end of FY2025, Catalyst Pharmaceuticals reported Cash & Current Investments of $709.17 million, up 37.0% from FY2024.

  • Annual Cash & Current Investments has a five-year compound annual growth rate of 38.3% (FY2020 to FY2025).
  • Across earlier years, Cash & Current Investments came in at $517.55 million in FY2024 (+276.0%), $137.64 million in FY2023 (-53.9%), $298.4 million in FY2022 (+56.0%) and $191.27 million in FY2021 (+36.3%).
  • The Q1 2026 figure is the highest quarterly Cash & Current Investments in data going back to Q3 2010.
  • On a year-over-year basis, Cash & Current Investments has increased for nine consecutive quarters, with growth averaging 117.0% over the last eight quarters.
  • Peak year-over-year performance for Cash & Current Investments in the last five years was growth of 276.0% in Q4 2024, against a decline of 53.9% in Q4 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at $709.17 million (Q4 2025), $689.89 million (Q3 2025) and $652.8 million (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 20.76 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 6.57 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 9.92 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.97 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 3.18 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.70 Bn
10 Catalyst Pharmaceuticals 3.85 Bn 1.04 Bn 134.92 Mn 755.86 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 755.86 Mn
Dec 31, 2025 709.17 Mn
Sep 30, 2025 689.89 Mn
Jun 30, 2025 652.80 Mn
Mar 31, 2025 580.66 Mn
Dec 31, 2024 517.55 Mn
Sep 30, 2024 442.33 Mn
Jun 30, 2024 375.69 Mn
Mar 31, 2024 310.41 Mn
Dec 31, 2023 137.64 Mn
Sep 30, 2023 120.97 Mn
Jun 30, 2023 178.79 Mn
Mar 31, 2023 148.25 Mn
Dec 31, 2022 298.40 Mn
Sep 30, 2022 256.07 Mn
Jun 30, 2022 220.79 Mn
Mar 31, 2022 197.80 Mn
Dec 31, 2021 191.27 Mn
Sep 30, 2021 174.79 Mn
Jun 30, 2021 155.28 Mn
API Access

Catalyst Pharmaceuticals Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=CPRX&period=max&api_key=YOUR_API_KEY